Sitagliptin (Januvia™) is a new oral agent ... including T-cell activation and proliferation. Although the mechanism of action may indicate that DPP-4 inhibition is a promising treatment for ...

A deeper dive into data from the Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS ... thought to be the main mechanism by which the drug lowered cardiovascular deaths, since ...

However, the two drugs have a different mechanism of action, and liraglutide requires injection, while sitagliptin can be taken orally. Liraglutide promotes weight loss, and causes nausea in some ...

Treatment modalities for advanced solid pseudopapillary tumor of the pancreas. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text ...